InMed Pharmaceuticals Inc. (NASDAQ: INM) Stock Information | RedChip

InMed Pharmaceuticals Inc. (NASDAQ: INM) Listen to this Section


$0.15
+0.0042 ( +2.98% ) 89.9K

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Market Data


Open


$0.15

Previous close


$0.14

Volume


89.9K

Market cap


$1.33M

Day range


$0.14 - $0.15

52 week range


$0.12 - $2.08

Insider Ownership Transactions

Total Amount Purchased: -1,175.00 | $ -170.38

Date Type Amount Purchased Purchaser
2023-12-06 Sale -848.00 WOUDENBERG MICHAEL
2023-08-31 Sale -327.00 HSU ERIC C

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Feb 14, 2024
10-q Quarterly Reports 72 Feb 13, 2024
8-k 8K-related 19 Feb 09, 2024
8-k 8K-related 14 Jan 19, 2024
8-k 8K-related 15 Jan 16, 2024
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.